{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:27:29Z","timestamp":1791070049469,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.molimm.2009.05.018","type":"journal-article","created":{"date-parts":[[2009,7,29]],"date-time":"2009-07-29T09:12:46Z","timestamp":1248858766000},"page":"2801-2807","source":"Crossref","is-referenced-by-count":38,"title":["Autoimmune forms of thrombotic micorangiopathy and membranoproliferative glomerulonephritis: Indications for a disease spectrum and common pathogenic principles"],"prefix":"10.1016","volume":"46","author":[{"given":"Christine","family":"Skerka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Licht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Uzonyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Strobel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter F.","family":"Zipfel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mih\u00e1ly","family":"J\u00f3zsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2009.05.018_bib1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1053\/j.ajkd.2008.01.026","article-title":"Mutations in proteins of the alternative pathway of complement and the pathogenesis of atypical hemolytic uremic syndrome","volume":"52","author":"Abarrategui-Garrido","year":"2008","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.molimm.2009.05.018_bib2","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/jmg.2005.038315","article-title":"Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease)","volume":"43","author":"Abrera-Abeleda","year":"2006","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.molimm.2009.05.018_bib3","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1681\/ASN.2005010078","article-title":"Membranoproliferative glomerulonephritis type II (dense deposit disease): an update","volume":"16","author":"Appel","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molimm.2009.05.018_bib4","doi-asserted-by":"crossref","first-page":"25168","DOI":"10.1074\/jbc.272.40.25168","article-title":"Human factor H deficiency. Mutations in framework cysteine residues and block in H protein secretion and intracellular catabolism","volume":"272","author":"Ault","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2009.05.018_bib5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00281-007-0090-3","article-title":"Complement in glomerular injury","volume":"29","author":"Berger","year":"2007","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.molimm.2009.05.018_bib6","doi-asserted-by":"crossref","first-page":"6385","DOI":"10.4049\/jimmunol.180.9.6385","article-title":"A novel non-synonymous polymorphism (p.Arg240His) in C4b-binding protein is associated with atypical hemolytic uremic syndrome and leads to impaired alternative pathway cofactor activity","volume":"180","author":"Blom","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2009.05.018_bib7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1160\/TH07-12-0753","article-title":"Rituximab as pre-emptive treatment in patients with thrombotic thrombocytopenic purpura and evidence of anti-ADAMTS13 autoantibodies","volume":"101","author":"Bresin","year":"2009","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.molimm.2009.05.018_bib8","doi-asserted-by":"crossref","first-page":"16651","DOI":"10.1073\/pnas.0705079104","article-title":"Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction","volume":"104","author":"Coffey","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molimm.2009.05.018_bib9","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s00467-007-0616-x","article-title":"The thrombotic microangiopathies","volume":"23","author":"Copelovitch","year":"2008","journal-title":"Pediatr. Nephrol."},{"issue":"April (4)","key":"10.1016\/j.molimm.2009.05.018_bib10","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.4049\/jimmunol.120.4.1389","article-title":"Heterogeneity, polypeptide chain composition and antigenic reactivity of C3 nephritic factor","volume":"120","author":"Daha","year":"1978","journal-title":"J Immunol."},{"key":"10.1016\/j.molimm.2009.05.018_bib11","doi-asserted-by":"crossref","first-page":"755","DOI":"10.4049\/jimmunol.123.2.755","article-title":"Further evidence for the antibody nature of C3 nephritic factor (C3NeF)","volume":"123","author":"Daha","year":"1979","journal-title":"J Immunol."},{"key":"10.1016\/j.molimm.2009.05.018_bib12","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1056\/NEJMc0809959","article-title":"Eculizumab for congenital atypical hemolytic-uremic syndrome","volume":"360","author":"Gruppo","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2009.05.018_bib13","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/01.ASN.0000115702.28859.A7","article-title":"Heterozygous and homozygous factor h deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases","volume":"15","author":"Dragon-Durey","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molimm.2009.05.018_bib14","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1681\/ASN.2004050380","article-title":"Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome","volume":"16","author":"Dragon-Durey","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molimm.2009.05.018_bib15","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/ncpneph0670","article-title":"Does hemolytic uremic syndrome differ from thrombotic thrombocytopenic purpura?","volume":"3","author":"Fakhouri","year":"2007","journal-title":"Nat. Clin. Pract. Nephrol."},{"key":"10.1016\/j.molimm.2009.05.018_bib16","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1182\/blood-2006-02-006064","article-title":"Prognostic value of anti-ADAMTS 13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS 13 activity","volume":"109","author":"Ferrari","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2009.05.018_bib17","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1182\/blood-2008-01-133702","article-title":"Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome","volume":"112","author":"Fremeaux-Bacchi","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2009.05.018_bib18","first-page":"905","article-title":"Hemolytic-uremic syndrome: bilateral necrosis of the renal cortex in acute acquired hemolytic anemia","volume":"85","author":"Gasser","year":"1955","journal-title":"Schweiz Med. Wochenschrift"},{"key":"10.1016\/j.molimm.2009.05.018_bib19","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/ki.2008.354","article-title":"C3 deposition glomerulopathy due to a functional Factor H defect","volume":"75","author":"Habbig","year":"2009","journal-title":"Kidney Int."},{"key":"10.1016\/j.molimm.2009.05.018_bib20","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/S0002-9440(10)64481-1","article-title":"The molecular basis for hereditary porcine membranoproliferative glomerulonephritis type II: point mutations in the factor H coding sequence block protein secretion","volume":"161","author":"Hegasy","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.molimm.2009.05.018_bib21","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1681\/ASN.2006091069","article-title":"Hemolytic uremic syndrome: a factor H mutation (E1172Stop) causes defective complement control at the surface of endothelial cells","volume":"18","author":"Heinen","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molimm.2009.05.018_bib22","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/humu.9408","article-title":"De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome","volume":"27","author":"Heinen","year":"2006","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.molimm.2009.05.018_bib23","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1172\/JCI117751","article-title":"Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency","volume":"95","author":"Hogasen","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molimm.2009.05.018_bib24","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0002-9440(10)61205-9","article-title":"Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site","volume":"167","author":"Jokiranta","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.molimm.2009.05.018_bib25","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.4049\/jimmunol.163.8.4590","article-title":"Nephritogenic lambda light chain dimer: a unique human miniautoantibody against complement factor H","volume":"163","author":"Jokiranta","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2009.05.018_bib26","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1182\/blood-2007-09-109876","article-title":"Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1\/CFHR3 deficiency","volume":"111","author":"Jozsi","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2009.05.018_bib27","first-page":"251","article-title":"Attachment of the soluble complement regulator factor H to cell and tissue surfaces: relevance for pathology","volume":"19","author":"Jozsi","year":"2004","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.molimm.2009.05.018_bib28","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1016\/j.molimm.2006.12.001","article-title":"The C-terminus of complement factor H is essential for host cell protection","volume":"44","author":"Jozsi","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2009.05.018_bib29","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1182\/blood-2007-02-071472","article-title":"Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome","volume":"110","author":"Jozsi","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2009.05.018_bib30","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.it.2008.04.008","article-title":"Factor H family proteins and human diseases","volume":"29","author":"Jozsi","year":"2008","journal-title":"Trends Immunol."},{"key":"10.1016\/j.molimm.2009.05.018_bib31","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev.med.59.060106.185110","article-title":"Complement regulatory genes and hemolytic uremic syndromes","volume":"59","author":"Kavanagh","year":"2008","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.molimm.2009.05.018_bib32","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1093\/ndt\/gfn063","article-title":"Successful pre-transplant management of a patient with anti-factor H autoantibodies-associated haemolytic uraemic syndrome","volume":"23","author":"Kwon","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.molimm.2009.05.018_bib33","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/35097008","article-title":"Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura","volume":"413","author":"Levy","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2009.05.018_bib34","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/sj.ki.5000269","article-title":"Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II)","volume":"70","author":"Licht","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.molimm.2009.05.018_bib35","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.4049\/jimmunol.174.10.6250","article-title":"Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with lipoprotein","volume":"174","author":"McRae","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2009.05.018_bib36","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1172\/JCI16651","article-title":"Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome","volume":"111","author":"Manuelian","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molimm.2009.05.018_bib37","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2249.2008.03798.x","article-title":"Lack of association between polymorphisms in C4b-binding protein and atypical haemolytic uraemic syndrome in the Spanish population","volume":"155","author":"Martinez-Barricarte","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.molimm.2009.05.018_bib38","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1084\/jem.175.4.939","article-title":"Activation of the alternative pathway of complement by monoclonal lambda light chains in membranoproliferative glomerulonephritis","volume":"175","author":"Meri","year":"1992","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molimm.2009.05.018_bib39","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.molimm.2006.08.004","article-title":"Genetic analysis of the complement factor H related 5 gene in haemolytic uraemic syndrome","volume":"44","author":"Monteferrante","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2009.05.018_bib40","first-page":"21","volume":"24","author":"Moschcowitz","year":"1924","journal-title":"Proc. N.Y. Pathol. Soc."},{"key":"10.1016\/j.molimm.2009.05.018_bib41","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1160\/TH08-05-0317","article-title":"Shiga toxins, glycosphingolipid diversity, and endothelial cell injury","volume":"101","author":"M\u00fcthing","year":"2009","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.molimm.2009.05.018_bib42","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1681\/ASN.2005010086","article-title":"Complement factor H mutation in familial thrombotic thrombocytopenic purpura with ADAMTS13 deficiency and renal involvement","volume":"16","author":"Noris","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molimm.2009.05.018_bib43","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1681\/ASN.2004100861","article-title":"Hemolytic uremic syndrome","volume":"16","author":"Noris","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molimm.2009.05.018_bib44","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1056\/NEJMc0808527","article-title":"Eculizumab for atypical hemolytic-uremic syndrome","volume":"360","author":"N\u00fcrnberger","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2009.05.018_bib45","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1365-2249.2006.03071.x","article-title":"The C-terminus of complement regulator Factor H mediates target recognition: evidence for a compact conformation of the native protein","volume":"144","author":"Oppermann","year":"2006","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.molimm.2009.05.018_bib46","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2249.2007.03574.x","article-title":"Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals","volume":"151","author":"Pickering","year":"2008","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.molimm.2009.05.018_bib47","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/ng912","article-title":"Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H","volume":"31","author":"Pickering","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molimm.2009.05.018_bib48","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1084\/jem.20070301","article-title":"Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains","volume":"204","author":"Pickering","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molimm.2009.05.018_bib49","first-page":"608","article-title":"Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice","volume":"118","author":"Rose","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molimm.2009.05.018_bib50","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1182\/blood-2008-02-078170","article-title":"Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura","volume":"112","author":"Sadler","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2009.05.018_bib51","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.molimm.2004.01.003","article-title":"Functional analysis in serum from atypical hemolytic uremic syndrome patients reveals impaired protection of host cells associated with mutations in factor H","volume":"41","author":"Sanchez-Corral","year":"2004","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2009.05.018_bib52","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1086\/344515","article-title":"Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome","volume":"71","author":"Sanchez-Corral","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molimm.2009.05.018_bib53","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jmg.2006.045328","article-title":"Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome","volume":"44","author":"Servais","year":"2007","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.molimm.2009.05.018_bib54","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1160\/TH08-05-0322","article-title":"Autoantibodies in haemolytic uraemic syndrome (HUS)","volume":"101","author":"Skerka","year":"2009","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.molimm.2009.05.018_bib55","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1681\/ASN.2007030356","article-title":"New approaches to the treatment of dense deposit disease","volume":"18","author":"Smith","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molimm.2009.05.018_bib56","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1097\/01.ASN.0000060805.04118.4C","article-title":"Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura","volume":"14","author":"Tsai","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molimm.2009.05.018_bib57","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura","volume":"339","author":"Tsai","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2009.05.018_bib58","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.1371\/journal.pmed.0030431","article-title":"Atypical haemolytic uraemic syndrome associated with a hybrid complement gene","volume":"3","author":"Venables","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.molimm.2009.05.018_bib59","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/MNH.0b013e3280bdc0f4","article-title":"Dense deposit disease: new insights","volume":"16","author":"Walker","year":"2007","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.molimm.2009.05.018_bib60","unstructured":"Wigger, M., Dr\u00fcckler, E., Jozsi, M., Skerka, C., Zipfel, P.F., Haffner, D., 2009. Treatment of atypical HUS due to factor H autoantibodies and CFHR1\/CFHR3 deficiency with mycophenolate mofetil: 12 month follow-up. Abstract presented at the International Conference on Current diagnosis and therapy of haemolytic uraemic syndrome (HUS), Innsbruck, 18\u201320 May 2009, Austria."},{"key":"10.1016\/j.molimm.2009.05.018_bib61","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1371\/journal.pgen.0030041","article-title":"Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome","volume":"3","author":"Zipfel","year":"2007","journal-title":"PLoS Genet."},{"key":"10.1016\/j.molimm.2009.05.018_bib62","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.molimm.2005.06.015","article-title":"Complement and diseases: defective alternative pathway control results in kidney and eye diseases","volume":"43","author":"Zipfel","year":"2006","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2009.05.018_bib63","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1055\/s-2006-939770","article-title":"The role of defective complement control in hemolytic uremic syndrome","volume":"32","author":"Zipfel","year":"2006","journal-title":"Semin. Thromb. Hemost."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016158900900234X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016158900900234X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T01:19:42Z","timestamp":1685063982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016158900900234X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":63,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S016158900900234X"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2009.05.018","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1167978.630083","asserted-by":"object"}]},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}